"Hyperphosphatemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.
Descriptor ID |
D054559
|
MeSH Number(s) |
C18.452.750.199
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperphosphatemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperphosphatemia".
This graph shows the total number of publications written about "Hyperphosphatemia" by people in this website by year, and whether "Hyperphosphatemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 1 | 0 | 1 |
2017 | 3 | 0 | 3 |
2018 | 4 | 2 | 6 |
2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hyperphosphatemia" by people in Profiles.
-
Severe hyperphosphatasemia and severe acute respiratory syndrome coronavirus 2 infection in children. Blood Coagul Fibrinolysis. 2020 Dec; 31(8):575-577.
-
Dysregulated Mineral Metabolism in AKI. Semin Nephrol. 2019 01; 39(1):41-56.
-
Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies. J Clin Invest. 2018 12 03; 128(12):5368-5373.
-
[Hyperphosphatemia in dialysis: which binder?] G Ital Nefrol. 2018 Sep; 35(5).
-
[Update 2017 of the KDIGO guidelines on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). What are the real changes?] G Ital Nefrol. 2018 May; 35(3).
-
Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-?B. J Am Soc Nephrol. 2018 06; 29(6):1636-1648.
-
Impact of Serum Phosphate in Mechanically Ventilated Patients With Severe Sepsis and Septic Shock. J Intensive Care Med. 2020 May; 35(5):485-493.
-
Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide. Am J Nephrol. 2018; 47(3):153-161.
-
Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort. Am J Kidney Dis. 2017 Sep; 70(3):377-385.
-
Use of Phosphorus Binders among Non-Dialysis Chronic Kidney Disease Patients and Mortality Outcomes. Am J Nephrol. 2017; 45(5):431-441.